About jim

This author has not yet filled in any details.
So far jim has created 24 blog entries.

Immunotherapy of Solid Tumor Cancers: Role of Cancer Associated Fibroblasts

Cancer therapy traditionally involves surgery, radiation or chemotherapy to kill cancer cells that are normal cells lacking control that limit growth.  Cancer cells produce continually growing tumors that spread to other tissues, and eventually kill. Since the early 1990’s, other targeted therapies have been developed with fewer side-effects. During 2017, the first CAR-T immunotherapies were [...]

2018-03-06T00:38:13+00:00 December 12th, 2017|

Vitro Biopharma Files Patent for its Novel Stem Cell Line with Broad Application to Stem Cell Therapies

Golden, Colorado—November 21, 2017 —Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma, announced the filing of a USPTO patent application regarding a novel stem cell line and its application to treatment of a variety of conditions including skeletal muscular, neurological, immune system dysfunction and other diseases or injuries as well.  The new stem cell line [...]

2018-05-07T18:00:51+00:00 November 29th, 2017|

Anti-Aging Stem Cell Therapy Improves Quality of Life

Scientists at the University of Miami Miller School of Medicine completed a clinical trial showing safety and efficacy of stem cell therapy in treatment of frailty, a common aging symptom caused by reduced function of stem cells and inflammation.1 Stem cells in the body serve several functions including repair and regeneration of damaged tissues, production [...]

2018-03-06T00:43:54+00:00 October 31st, 2017|

Vitro Biopharma Reports Positive Clinical Trial Results of Stem Cell Activation Therapy for Autism

Golden, Colorado—August 8, 2017 —Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma, announced initial results of a Phase I clinical trial testing the effects of its proprietary stem cell activation compounds for safety and efficacy in autistic patients. Safety was the primary endpoint of our non-randomized, pilot study and our preliminary data indicate a low [...]

2018-05-07T18:00:51+00:00 August 9th, 2017|

Vitro Biopharma Receives Funding to Expand its Stem Cell Therapies

Golden, Colorado—March 29, 2017 —Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma, announced the completion of a bridge loan in the amount of $125,000 and the execution of a Memorandum of Understanding (“MOU”) outlining the terms of a larger, subsequent financing to provide a total of not less than $1.7 million.  Completion of the subsequent [...]

2018-05-07T18:00:52+00:00 April 14th, 2017|

Vitro Biopharma Files New Patents for Stem Cell Therapy of Neurological Conditions

Golden, Colorado—November 7, 2016 —Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma, announced the filing of four new patent applications at the United States Patent Office seeking protection of its proprietary stem cell products and technology related to treatment of neurological conditions.  The new patents cover technology related to activation of stem cells within the [...]

2018-05-07T18:00:52+00:00 November 14th, 2016|

Recent Advances in Stem Cell Therapy of Stroke

An interim report of a clinical trial of intracerebral injection of stem cells adds to a growing body of evidence supporting safety and efficacy of stem cell therapy for stroke.  A clinical team led by Dr. Gary Steinberg at Stanford University Medical Center reported results from 16 patients who received stereotactic injections into damaged brain [...]

2018-03-13T01:35:09+00:00 June 13th, 2016|

Vitro Biopharma Launches New Products to Advance Breast Cancer Treatment

Golden, Colorado—May 3, 2016 —Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma, announced the launch of breast cancer CAFs (cancer-associated fibroblasts) that provide additional tools for drug discovery in the quest to eradicate cancer. CAFs reside within tumor tissue and serve various functions including suppression of immune responses to cancerous cells, support of tumor cell growth and enhancement of [...]

2018-05-07T18:00:52+00:00 May 4th, 2016|

Vitro Biopharma Announces Early 2016 Results: Increased Revenue and Expansion Activities to Fuel Growth

Golden, Colorado—March 1, 2016 —Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced increased revenues during its first fiscal quarter 2016 of 143% compared to the same period in 2015, predominately due to further increased sales of its cell lines and MSC-Gro™ Brand of cell culture media products. Vitro Biopharma’s cell line product sales are being driven by [...]

2018-05-07T18:00:52+00:00 March 7th, 2016|

Vitro Biopharma Advances Stem Cell Activation Therapy for Concussion

Golden, Colorado—December 29, 2015 —Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced new developments of its stem cell activation therapy for concussion.  Dr. Omula’s research tying repetitive concussion to chronic traumatic encephalopathy is chronicled in the recently released movie, “Concussion.”  Vitro Biopharma is a leader in the field of stem cell activation therapy now [...]

2018-05-07T18:00:52+00:00 January 12th, 2016|